Biotech ETFs were initially among the biggest winners of Donald Trump’s surprise election win last month, but the early euphoria has now turned to a massive sell-off once again.
Just take a look at the three-month chart for the iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB), which is the largest biotech-focused fund with nearly $8 billion in assets under management: